Detalhe da pesquisa
1.
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm3 minimum size threshold for multidisciplinary team referral.
Thorax
; 78(2): 202-206, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428100
2.
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
Thorax
; 77(10): 1036-1040, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863766
3.
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896207
4.
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001.
Int J Gynecol Cancer
; 32(1): 93-100, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799418
5.
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Gynecol Oncol
; 161(2): 502-507, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612336
6.
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Int J Gynecol Cancer
; 31(1): 134-138, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097567
7.
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application.
Clin Trials
; 16(5): 502-511, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347385
8.
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet
; 387(10023): 1066-1074, 2016 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27025186
9.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Lancet Oncol
; 16(8): 928-36, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115797
10.
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and industry partners - a new Model D for drug and medical device development.
Int J Gynecol Cancer
; 30(6): 730-734, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404377
11.
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.
Int J Gynecol Cancer
; 23(7): 1339-43, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970159
12.
A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer.
PLoS One
; 18(3): e0281798, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952534
13.
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Lancet Public Health
; 8(2): e130-e140, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709053
14.
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.
BMJ Open Respir Res
; 10(1)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321665
15.
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-up.
Lung Cancer
; 176: 75-81, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621036
16.
The reporting of pulmonary nodule results by letter in a lung cancer screening setting.
Lung Cancer
; 168: 46-49, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487105
17.
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme.
Lung Cancer
; 173: 94-100, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179541
18.
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.
Clin Cancer Res
; 26(18): 4748-4755, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669375
19.
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 106(4): 733-742, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809876
20.
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.
Pediatr Infect Dis J
; 25(6): 533-7, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16732152